Analysts expect Krystal Biotech, Inc. to report revenue of 118.87 M for Q3 26, against a range of 109.60 M to 128.15 M. The most recent reported quarter, Q2 26, came in at 119.22 M, a 0.6% beat against the 118.50 M consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 83.84 M | 91.14 M | 88.18 M | 96.04 M | 97.80 M | 107.11 M | 116.36 M | 119.22 M | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 91.47 M | 103.33 M | 97.42 M | 105.22 M | 92.96 M | 117.61 M | 128.88 M | 122.72 M | 128.15 M | 152.98 M | 142.81 M | 150.58 M | 175.86 M | 170.25 M | 235.15 M | 222.73 M | ||||||||||
| Low Estimate | 79.21 M | 85.42 M | 82.82 M | 90.40 M | 83.77 M | 97.64 M | 108.86 M | 114.27 M | 109.60 M | 125.55 M | 125.26 M | 138.44 M | 152.31 M | 141.72 M | 200.90 M | 199.90 M | ||||||||||
| Consensus Estimate | 85.34 M | 94.38 M | 90.12 M | 97.81 M | 88.37 M | 107.62 M | 118.87 M | 118.50 M | 118.87 M | 139.26 M | 134.04 M | 144.51 M | 164.09 M | 155.99 M | 218.02 M | 211.31 M |
Analysts expect Krystal Biotech, Inc. to report earnings per share of 1.89 for Q3 26, against a range of 1.82 to 1.96. The most recent reported quarter, Q2 26, came in at 1.79, a 10.5% beat against the 1.62 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 0.91 | 1.52 | 1.20 | 1.29 | 2.66 | 1.70 | 1.83 | 1.79 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 0.99 | 1.17 | 1.44 | 1.32 | 1.11 | 1.61 | 1.67 | 1.71 | 1.96 | 1.98 | 2.27 | 2.40 | 2.59 | 2.28 | 3.30 | 3.29 | ||||||||||
| Low Estimate | 0.91 | 1.07 | 1.22 | 1.18 | 0.97 | 1.41 | 1.51 | 1.53 | 1.82 | 1.66 | 1.89 | 2.14 | 2.25 | 2.08 | 2.90 | 2.81 | ||||||||||
| Consensus Estimate | 0.95 | 1.12 | 1.33 | 1.25 | 1.04 | 1.51 | 1.59 | 1.62 | 1.89 | 1.82 | 2.08 | 2.27 | 2.42 | 2.18 | 3.10 | 3.05 |
Pull Wall Street consensus for Krystal Biotech, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=KRYS&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "KRYS", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=KRYS&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();